The presentation focused on the need for better cross-border access to clinical trials, especially for patients suffering from rare and serious illnesses. It highlighted the importance of raising awareness among patient organisations and advocates. 
For the initiative to succeed, patients and patient organisations must play an active role by leveraging existing patient experiences to identify needs and ensure that the patient&rsquos voice is heard and represented. Once the information is collected from all stakeholders, concrete recommendations and guidelines will be implemented and made freely available. 
The team called for all stakeholders to engage with the project and ensure that the needs and interests of patients are prioritised and met.